IL2 and plasma cell myeloma: It is worth mentioning that the therapeutic use of IL-2 together with TNF-α has been shown to influence the elimination of the tumour in a mouse model of myeloma, emphasizing the importance of IL-2 in anti-cancer therapy [16].